Brainsway Ltd
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, sc… Read more
Brainsway Ltd (BWAY) - Total Assets
Latest total assets as of September 2025: $113.06 Million USD
Based on the latest financial reports, Brainsway Ltd (BWAY) holds total assets worth $113.06 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Brainsway Ltd - Total Assets Trend (2000–2024)
This chart illustrates how Brainsway Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Brainsway Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Brainsway Ltd's total assets of $113.06 Million consist of 84.5% current assets and 15.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 73.5% |
| Accounts Receivable | $4.60 Million | 4.9% |
| Inventory | $4.43 Million | 4.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2000–2024)
This chart illustrates how Brainsway Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Brainsway Ltd's current assets represent 84.5% of total assets in 2024, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 73.5% of total assets in 2024, up from 7.1% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2000.
- Asset Diversification: The largest asset category is accounts receivable at 4.9% of total assets.
Brainsway Ltd Competitors by Total Assets
Key competitors of Brainsway Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Brainsway Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Brainsway Ltd generates 0.43x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Brainsway Ltd generates $ 3.10 in net profit.
Brainsway Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.19 | 4.52 | 3.57 |
| Quick Ratio | 3.02 | 4.23 | 3.51 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $56.94 Million | $ 44.64 Million | $ 17.50 Million |
Brainsway Ltd - Advanced Valuation Insights
This section examines the relationship between Brainsway Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.90 |
| Latest Market Cap to Assets Ratio | 2.39 |
| Asset Growth Rate (YoY) | 49.8% |
| Total Assets | $94.32 Million |
| Market Capitalization | $225.45 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Brainsway Ltd's assets at a significant premium ( 2.39x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Brainsway Ltd's assets grew by 49.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Brainsway Ltd (2000–2024)
The table below shows the annual total assets of Brainsway Ltd from 2000 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $94.32 Million | +49.77% |
| 2023-12-31 | $62.97 Million | -2.33% |
| 2022-12-31 | $64.48 Million | -14.86% |
| 2021-12-31 | $75.73 Million | +122.67% |
| 2020-12-31 | $34.01 Million | -12.20% |
| 2019-12-31 | $38.74 Million | +64.12% |
| 2018-12-31 | $23.60 Million | -12.68% |
| 2017-12-31 | $27.03 Million | +35.39% |
| 2016-12-31 | $19.96 Million | -10.25% |
| 2015-12-31 | $22.24 Million | -13.69% |
| 2014-12-31 | $25.77 Million | +44.40% |
| 2013-12-31 | $17.85 Million | +66.98% |
| 2012-12-31 | $10.69 Million | -86.17% |
| 2000-12-31 | $77.27 Million | -- |